Elacridar-d4

SI-6207

Elacridar-d₄, >98% (HPLC)

CAS No. : [1189481-51-3]

Synonyms : GW-120918-d₄; GF-120918-d₄; GW-0918-d₄; GG-918-d₄

IUPAC Name : N-(4-(2-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl-1,1,2,2-d₄)phenyl)-5-methoxy-9-oxo-9,10-dihydroacridine-4-carboxamide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Elacridar‑d₄ is a stable‑isotope–labelled analog of Elacridar, an orally active P‑gp/BCRP inhibitor widely used to probe efflux transporter function. The deuterium label facilitates analytical and pharmacokinetic studies focused on brain distribution and cancer drug‑resistance pathways.

References : Sane R. et al.: Drug Metab. Dispos., 40(8), 1612-9, 2012; Sato H. et al.: Eur. J. Pharmacol., 746, 258-66, 2015.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.